| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |